Myocardial ischemia and reperfusion: a murine model - PubMed (original) (raw)
Myocardial ischemia and reperfusion: a murine model
L H Michael et al. Am J Physiol. 1995 Dec.
Abstract
Myocardial ischemia followed by reperfusion promotes a complex series of inflammatory reactions as noted in a variety of large animal studies. With development of genetically altered mice, there is intense interest in developing murine models to study mechanisms operative in cardiovascular disease. We developed a mouse model to study coronary artery occlusion and reperfusion effects and the method required to perform these studies both acutely and chronically. In mice, we applied a left anterior descending coronary artery occlusion either permanently or for 30 or 60 min followed by reperfusion allowing flow through the previously occluded coronary artery bed. Reperfusion was documented visually as well as by using Doppler ultrasound and histopathological techniques. The area at risk (AAR) and infarct size (IS) were assessed by EVans blue dye and triphenyltetrazolium chloride staining with computerized planimetry using an image analysis software program. The infarct as percentage of AAR and IS as percentage of the left ventricle in 13 mice with permanent occlusion was 68.6 +/- 4.4 and 28.0 +/- 2.8%, respectively. Reperfusion after occlusions of 60 and 30 min resulted in a significant decrease in IS as a percentage of the AAR compared with permanent occlusion. Histological examination of the ischemic and reperfused myocardium shows infiltration of leukocytes into the ischemic region as well as contraction bands classically associated with reperfusion. This new model allows assessment of AAR, IS, cardiac function, and pathophysiology in the mouse. With the current technology to develop genetically altered mice for overexpression or targeted mutations of various genes, this model is used to understand the complex pathophysiology of ischemia and reperfusion injury.
Similar articles
- Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size.
Lee R, Nitta T, Schmid RA, Schuessler RB, Harris KM, Gay WA Jr. Lee R, et al. Ann Thorac Surg. 1998 May;65(5):1353-9. doi: 10.1016/s0003-4975(98)00186-6. Ann Thorac Surg. 1998. PMID: 9594866 - Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.
Birnbaum Y, Hale SL, Kloner RA. Birnbaum Y, et al. J Mol Cell Cardiol. 1997 Feb;29(2):657-66. doi: 10.1006/jmcc.1996.0308. J Mol Cell Cardiol. 1997. PMID: 9140823 - Proximal coronary hemodynamic changes evaluated by intracardiac echocardiography during myocardial ischemia and reperfusion in a canine model.
Han B, Wei M. Han B, et al. Echocardiography. 2008 Mar;25(3):312-20. doi: 10.1111/j.1540-8175.2007.00591.x. Echocardiography. 2008. PMID: 18307445 - Methods employed for induction and analysis of experimental myocardial infarction in mice.
Borst O, Ochmann C, Schönberger T, Jacoby C, Stellos K, Seizer P, Flögel U, Lang F, Gawaz M. Borst O, et al. Cell Physiol Biochem. 2011;28(1):1-12. doi: 10.1159/000331708. Epub 2011 Aug 16. Cell Physiol Biochem. 2011. PMID: 21865843 Review. - The representative porcine model for human cardiovascular disease.
Suzuki Y, Yeung AC, Ikeno F. Suzuki Y, et al. J Biomed Biotechnol. 2011;2011:195483. doi: 10.1155/2011/195483. Epub 2010 Dec 28. J Biomed Biotechnol. 2011. PMID: 21253493 Free PMC article. Review.
Cited by
- Canonical and Non-Canonical Roles of Connexin43 in Cardioprotection.
Rusiecka OM, Montgomery J, Morel S, Batista-Almeida D, Van Campenhout R, Vinken M, Girao H, Kwak BR. Rusiecka OM, et al. Biomolecules. 2020 Aug 23;10(9):1225. doi: 10.3390/biom10091225. Biomolecules. 2020. PMID: 32842488 Free PMC article. Review. - Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of nonreperfused myocardial infarction.
Hanna A, Shinde AV, Frangogiannis NG. Hanna A, et al. Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H948-H964. doi: 10.1152/ajpheart.00318.2020. Epub 2020 Sep 4. Am J Physiol Heart Circ Physiol. 2020. PMID: 32886000 Free PMC article. - Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.
Gravning J, Ørn S, Kaasbøll OJ, Martinov VN, Manhenke C, Dickstein K, Edvardsen T, Attramadal H, Ahmed MS. Gravning J, et al. PLoS One. 2012;7(12):e52120. doi: 10.1371/journal.pone.0052120. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284892 Free PMC article. - Canonical NF-κB p65, but Not p105, Contributes to IL-1β-Induced IL-8 Expression in Cardiac Fibroblasts.
Mizuno M, Nakano R, Nose S, Matsumura M, Nii Y, Kurogochi K, Sugiya H, Uechi M. Mizuno M, et al. Front Immunol. 2022 Apr 20;13:863309. doi: 10.3389/fimmu.2022.863309. eCollection 2022. Front Immunol. 2022. PMID: 35514973 Free PMC article. - CAR links hypoxia signaling to improved survival after myocardial infarction.
Freiberg F, Thakkar M, Hamann W, Lopez Carballo J, Jüttner R, Voss FK, Becher PM, Westermann D, Tschöpe C, Heuser A, Rocks O, Fischer R, Gotthardt M. Freiberg F, et al. Exp Mol Med. 2023 Mar;55(3):643-652. doi: 10.1038/s12276-023-00963-9. Epub 2023 Mar 20. Exp Mol Med. 2023. PMID: 36941462 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources